Bailey Jeffrey Allen (CIK 0001500210)

Latest company ownership

Shares held
229,407
Last filed at
Sep 3, 2015
Confidence Score
50.0
2025Q4
Confidence Score History
2015Q3 2025Q4
Shares held
54,500
Last filed at
Jun 17, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2019Q4 2025Q4
Shares held
22,775
Last filed at
Nov 24, 2025
Confidence Score
47.2
2025Q4
Confidence Score History
2024Q4 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Nov 21, 2025 Nov 24, 2025 Aurinia Pharmaceuticals Inc. Director Sell 46.3 -2,716 -10.65% ✗ $42.6K
Nov 8, 2024 Nov 12, 2024 Aurinia Pharmaceuticals Inc. Director Sell 46.3 -4,557 -25.44% ✗ $38.4K
Sep 23, 2020 Sep 23, 2020 abrdn World Healthcare Fund Director Buy 91.3 +710 100.00% ✗ $10.1K
Sep 23, 2020 Sep 23, 2020 abrdn Healthcare Opportunities Fund Director Buy 91.3 +570 100.00% ✗ $10.1K
Sep 23, 2020 Sep 23, 2020 abrdn Healthcare Investors Director Buy 90.0 +490 100.00% ✗ $10K
Sep 22, 2020 Sep 23, 2020 abrdn Life Sciences Investors Director Buy 91.3 +580 100.00% ✗ $10K
Nov 14, 2019 Nov 18, 2019 Rein Therapeutics, Inc. Director Buy 91.3 +55,000 276.47% ✗ $28.1K
Nov 12, 2019 Nov 14, 2019 Rein Therapeutics, Inc. Director Buy 91.3 +19,894 100.00% ✗ $10.5K
Jul 17, 2015 Sep 3, 2015 Lantheus Holdings, Inc. CEO Sell 42.5 -13,020 -5.37% ✗ $92.8K